Navigation Links
Sarcoma Alliance Excited About New Drug Research
Date:6/25/2013

New York, N.Y. (PRWEB) June 25, 2013

The Sarcoma Alliance has high hopes for an experimental drug, TH-302, being studied around the world, Executive Director Arthur Beckert said Tuesday.

"I'm very confident of this drug in sarcoma," said William Tap, MD, section chief for sarcoma oncology at Memorial Sloan-Kettering Cancer Center in New York. There are more than 50 subtypes of sarcoma, a rare cancer of bone, muscle, nerve, fat and other connective tissues. It can arise anywhere in the body, from newborn on up.

He gave an update on TH-302 this month at the American Society of Clinical Oncology’s annual meeting. The first findings may be available next year.

Ninety-five cancer centers in the U.S., Canada, Europe and Israel have signed up for the clinical trial, according to the National Institutes of Health. “Australia is coming aboard soon,” said Dr. Tap, the trial’s principal investigator.

Having this many study sites is amazing, compared with sarcoma research a decade ago, he said. The study is being done by Threshold Pharmaceuticals in conjunction with SARC (Sarcoma Alliance for Research Through Collaboration). SARC, founded in 2003 in Ann Arbor, Mich., brings together physicians and scientists from different institutions to collaborate on research.

(SARC is sometimes confused with the Sarcoma Alliance, which was founded in 1999 in Mill Valley, Calif., to provide information and support to people affected by sarcoma, Beckert said. Both are nonprofits.)

Dr. Tap said 338 patients have enrolled in the TH-302 trial so far, with a goal of 450. In one arm of the phase 3 trial, patients get doxorubicin (Adriamycin) and TH-302. In the other, they get only doxorubicin. Patients are selected at random to go into one arm or the other. He said the trial is enrolling patients who have intermediate- and hig
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools
2. Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma
3. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
4. VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
5. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
6. The Alliance for the Advancement of Adult Stem Cell Therapy and Research Recently Has Proven Stem Cells To Be Effective in Dilated Cardiomyopathy
7. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
8. ClearPath Workforce Management CEO Appointed Co-chair of Northern California Leadership Forum for Woman Owned Business Alliance
9. Campbell Alliance to Release New Forward-Looking Industry Report on Deal-Making Trends at the 2013 BIO International Convention
10. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
11. Alliance to Feed the Future Congratulates Our Farmers, Supports Education for Future Generations on National Agriculture Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... 2014 The Europe Thermal Protective ... to provide crucial revenue forecasts. It estimates the ... at a CAGR of 7.5%, from 2013 to ... Europe Thermal Protective Clothing market report for a ... supported by various tables and figures. , ...
(Date:11/27/2014)... Nov. 27, 2014 Research and ... "Global Palmitic Acid Industry Report 2014" report to ... The Global Palmitic Acid Industry Report 2014 ... state of the global palmitic acid industry. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:11/27/2014)... 2014 Spartan Bioscience today announced that ... Drug Safety (MFDS) regulatory approval for its Spartan ... in less than 60 minutes from a non-invasive cheek ... aid for doctors to determine therapeutic strategies for drugs ... some of the world’s most commonly prescribed drugs such ...
(Date:11/27/2014)... November 27, 2014 First ...   Elsevier , a world-leading provider ... is pleased to announce the launch of a new ... The launch of Extreme Mechanics ... at the forefront of applied sciences such as micro ...
Breaking Biology Technology:The Europe Thermal Protective Clothing market is estimated to grow up to $577.9 million by 2018 - Report by MicroMarket Monitor 2The Europe Thermal Protective Clothing market is estimated to grow up to $577.9 million by 2018 - Report by MicroMarket Monitor 3Global Palmitic Acid Industry Report 2014 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3
... Inc., today,announced the appointment of Lynn Marcus-Wyner, Ph.D., ... for managing the company,s,intellectual property strategy, activities, and ... President, General Counsel and Secretary., Dr. Marcus-Wyner ... Intellectual Assets US, she managed the United States ...
... Sept. 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX: SDI) ... terms with Toray,Industries Inc. of Japan to obtain ... for Toraymyxin(TM), a therapeutic for the treatment of,sepsis ... terms of the,agreement, the Company will seek FDA ...
... BROOMFIELD, Colo., Sept. 23 ARCA biopharma, ... Drug Administration (FDA) has,accepted a New Drug ... bucindolol, an investigational and pharmacologically unique,beta-blocker and ... chronic,heart failure. If approved by the FDA, ...
Cached Biology Technology:Codexis Names Vice President, Intellectual Property 2Spectral to bring anti-sepsis therapy to the U.S. market 2Spectral to bring anti-sepsis therapy to the U.S. market 3FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma 2FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma 3
(Date:11/21/2014)... 2014 According to a new ... (Video, RFID, Access Control, Intrusion Detection, Parking Management, Under ... Component Service Geography - Global Forecasts to 2020", published ... to be around $25 Billion in 2014 and is ... a CAGR of 8.69%. Browse 116 market ...
(Date:11/21/2014)... 2014  Earlier this year Donald Spector , ... one of the most prolific inventors in the world, ... from Smartphones to third party agencies. Spector envisioned this ... of the earliest known patents in this area. Now ... military, child care, elder care and hospital applications. This ...
(Date:11/21/2014)... 2014 Strict laws against distracted driving and ... North American and European automotive sector towards gesture recognition ... systems that are intuitive and able to retrieve information ... New analysis from Frost & Sullivan,s ... Europe and North ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... [Brown University] Just as a company creates new, better ... its bottom line, an international team of researchers led by ... and performance before flooding the environment with new, improved versions ... plants with the same ancestor, called a clade, begin to ...
... growth and spread of breast cancer tumors may be ... strategies: blocking the enzyme needed to "energize" cancer cells ... with minimum exposure to healthy tissues, indicate researchers at ... in Chicago, Ill. "Once breast cancer metastases ...
... with information on the size of the carbon footprint ... make better, environmentally friendly choices. A Michigan State ... of the journal Nature Climate Change , said ... with nutritional information, could offer at least a short-term ...
Cached Biology News:Like products, plants wait for optimal configuration before market success 2Interventional radiologists provide hope in delaying growth, spread of breast cancer 2Interventional radiologists provide hope in delaying growth, spread of breast cancer 3Nature paper calls for carbon labeling 2
... genetically engineered Klenow polymerase in which the 3 ... only the 5 to 3 polymerase activity. The ... the enzyme of choice for isotopic or biotin ... method, and for DNA sequencing by the Sanger ...
... a DNA-dependent RNA polymerase which is stringently ... efficiently synthesizes in vitro transcripts from almost ... a T7 promoter. Transcripts can be ... vitro translation, substrates in RNA processing systems, ...
... overproducer ATP: D-hexose 6- phosphotransferase/D-glucose-6-phosphate: ... unit of HK will phosphorylate ... 1 min at 25C at ... G6P-DH will oxidize 1 mol ...
Goat polyclonal to Haptoglobin ( Abpromise for all tested applications). Antigen: Affinity purified human haptoglobin. Entrez GeneID: 3240 Swiss Protein ID: P00738...
Biology Products: